Exercise Self-Efficacy, Body Composition, and Physical Activity in Men With Hypogonadism
A legfontosabb adatok
- Ki végzi
- Hacettepe University
- Hol
- Törökország2 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 45 fő, tervezett
- Kezdés
- 2026. okt. 20.
- Várható befejezés
- 2027. okt. 15.
- A vizsgálat típusa
- Megfigyeléses
- A regiszteradat frissítve
- 2026. november 9.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for men with low testosterone (hypogonadism) who are on testosterone replacement therapy (TRT). It studies how body makeup, confidence about exercise and physical activity are linked.
- Életkor
- 18 years or older
- Nem
- Men only
- A betegség stádiuma
- Confirmed male hypogonadism, primary or secondary. Symptoms have partly or fully gone away on TRT, and the doctor judges that the treatment works.
- Korábbi kezelés
- Must be receiving TRT now.
- Biomarker vagy leletérték
- Morning blood total testosterone level <300 ng/dL at diagnosis.
A részvétel fő kizáró okai
- Nerve, bone or joint, heart or lung conditions not caused by hypogonadism that limit physical activity
- Mental health disorders that affect exercise, such as major depressive disorder or psychosis
- Other hormone disorders affecting body makeup, such as uncontrolled or complicated diabetes (HbA1c >8.0% (64 mmol/mol)) or thyroid disease without confirmed normal thyroid levels
- Implanted heart devices or pacemakers, or other things that block body composition testing
- Long-term inflammatory diseases such as chronic kidney disease, inflammatory bowel disease, rheumatoid arthritis, lupus or ankylosing spondylitis; also, not able to read and write in Turkish
A regiszter feltételei, szó szerint
Mind a 11 feltétel megnézéseKevesebb
Ki vehet részt
- Confirmed diagnosis of male hypogonadism (primary or secondary; biochemically verified with a morning serum total testosterone level <300 ng/dL)
- Currently undergoing TRT with observed partial or complete symptom remission, evaluated as treatment-responsive by the clinician
- Aged 18 years or older
- Ability to read and write in Turkish
- Voluntary agreement to participate and signature on the informed consent form
Ki nem vehet részt
- Neurological, orthopedic, or cardiopulmonary conditions independent of hypogonadism that restrict physical activity capacity
- Diagnosed psychiatric disorders directly impacting exercise self-efficacy and physical activity (e.g., major depressive disorder, psychosis)
- Presence of conditions preventing bioelectrical impedance analysis (e.g., implanted cardiac devices/pacemakers)
- Chronic inflammatory conditions directly affecting body composition and physical capacity (e.g., chronic kidney disease, inflammatory bowel disease, rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis)
- Concomitant endocrine disorders significantly affecting body composition, including uncontrolled or complicated diabetes mellitus (HbA1c >8.0% or presence of diabetic nephropathy, neuropathy, retinopathy) or biochemically unverified euthyroid state in thyroid disease
- Visual or cognitive impairments preventing the reading and completion of study questionnaires
Ez a vizsgálat jelenleg itt érhető el: Törökország.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Male hypogonadism is a chronic endocrine condition characterized by deficient testosterone production, leading to adverse changes in body composition (decreased lean mass, increased fat mass) and various physical and psychological symptoms, including fatigue and reduced motivation. Although testosterone replacement therapy (TRT) is the primary medical treatment, its effectiveness in optimizing body composition largely depends on regular physical activity. However, the psychosocial mechanisms underlying exercise engagement in this specific population remain insufficiently explored.
A teljes eredeti leírásKevesebb
Exercise self-efficacy, an individual's confidence in their ability to perform physical activity, is a major determinant of exercise behavior. While its mediating role between body composition and physical activity has been shown in other clinical populations, it has not been investigated in men with hypogonadism, where low testosterone levels uniquely impair psychological well-being and drive.
The primary objective of this cross-sectional study is to evaluate the mediating role of exercise self-efficacy in the relationship between body composition and physical activity levels in men with hypogonadism receiving TRT. Additionally, the study explores the potential moderating effects of serum total testosterone levels and TRT duration, while controlling for depressive symptoms as a covariate. Findings from this study aim to provide evidence-based guidance for clinicians and physical therapists in designing targeted exercise interventions and timing rehabilitation strategies for hypogonadal patients.
A vizsgálat csoportja
- Men with Hypogonadism on TRT
Male patients aged 18 years or older who have been diagnosed with primary or secondary hypogonadism (biochemically verified morning serum total testosterone \<300 ng/dL) and are currently receiving testosterone replacement therapy (TRT).
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- The Mediating Role of Exercise Self-Efficacy in the Relationship Between Body Composition and Physical Activity in Men With Hypogonadism: A Cross-Sectional Study
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 15.
- A regiszteradat frissítve
- 2026. november 9.